Allan Jonathan

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2025-03-20	2025-03-19	Stoke Therapeutics Inc (STOK)	S Sale	1,945 -5.8% 8.27 USD 16,085	1,945 -5.8%	8.27	USD 16,085
2025-03-20	2025-03-18	Stoke Therapeutics Inc (STOK)	S Sale	2,266 -6.3% 8.67 USD 19,646	2,266 -6.3%	8.67	USD 19,646
2024-12-11	2024-12-09	Stoke Therapeutics Inc (STOK)	S Sale	1,552 -6.7% 12.99 USD 20,164	1,552 -6.7%	12.99	USD 20,164
2024-12-11	2024-12-09	Stoke Therapeutics Inc (STOK)	PS Planned sale	12,114 -34.5% 13.69 USD 165,814	12,114 -34.5%	13.69	USD 165,814
2024-12-10	2024-12-06	Stoke Therapeutics Inc (STOK)	S Sale	9,696 -21.6% 12.78 USD 123,891	9,696 -21.6%	12.78	USD 123,891
2024-05-22	2024-05-20	Stoke Therapeutics Inc (STOK)	PS Planned sale	8,599 -76.8% 15.04 USD 129,327	8,599 -76.8%	15.04	USD 129,327
2024-04-01	2024-03-28	Stoke Therapeutics Inc (STOK)	PS Planned sale	100 -3.7% 13.81 USD 1,381	100 -3.7%	13.81	USD 1,381
2024-04-01	2024-03-28	Stoke Therapeutics Inc (STOK)	PS Planned sale	5,026 -65.1% 13.19 USD 66,287	5,026 -65.1%	13.19	USD 66,287
2024-03-19	2024-03-19	Stoke Therapeutics Inc (STOK)	S Sale	2,349 -23.3% 6.10 USD 14,326	2,349 -23.3%	6.10	USD 14,326
2023-06-23	2023-06-21	Stoke Therapeutics Inc (STOK)	PS Planned sale	1,948 -100.0% 13.48 USD 26,252	1,948 -100.0%	13.48	USD 26,252